Catheter-Directed Thrombolysis of Pulmonary Embolism

Overview

4.5 out of 5 (35 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

2 May 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a significant global health burden. An estimated 10 million individuals experience VTE annually, resulting in over 500,000 fatalities in Europe and a range of 100,000 to 300,000 deaths in the United States. PE, as the third leading cause of cardiovascular mortality behind heart attack and stroke, presents a complex treatment challenge. While systemic thrombolytic therapy remains part of the PE management arsenal, its effectiveness and safety, particularly for the growing intermediate-risk group, remain debated. Catheter-directed thrombolysis (CDT) has emerged as a potential paradigm shift in the therapeutic landscape of PE. This minimally invasive technique, delivering thrombolytic agents directly to the clot via catheterization, promises targeted therapy with potentially reduced systemic bleeding risks.

This activity on CDT for pulmonary embolism PE is crucial for healthcare professionals involved in PE management. This activity delves into the science and evidence behind CDT, examining its effectiveness, safety, and potential benefits for different patient groups. Participants will gain insights into CDT implementation's technical considerations and possible limitations, identifying knowledge gaps and outlining future research directions. Key endpoints like mortality, hemodynamic improvement, and bleeding risks will be scrutinized within this specific context. By staying informed about the latest advancements and best practices in CDT, healthcare professionals can enhance their knowledge and skills, ultimately improving patient outcomes in the management of PE.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate candidates for catheter-directed thrombolysis in acute pulmonary embolism management based on clinical presentation, risk factors, and imaging findings.

  • Apply evidence-based guidelines and protocols for catheter-directed thrombolysis administration, dosage, and monitoring in managing acute pulmonary embolism.

  • Select appropriate catheterization techniques and thrombolytic agents based on patient characteristics and clot location for catheter-directed thrombolysis.

  • Collaborate with interventional radiologists and cardiologists to optimize catheter-directed thrombolysis procedures and outcomes in acute pulmonary embolism management.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 1.00 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Shantel B. on 4/29/2021

Mary C. on 11/14/2021

Joseph M. on 4/7/2022

Russell C. on 7/27/2022

Hardeep A. on 9/27/2022

Philip P. on 12/3/2022

long h. on 12/19/2022

Christina D. on 3/25/2023

Sandy M. on 5/9/2023

TERRIE G. on 7/16/2023

Silas I. on 7/18/2023

John H. on 7/24/2023

Ginger M. on 8/16/2023

None

Richard P. on 8/23/2023

William T. on 9/3/2023

Charlie C. on 9/8/2023

Raymond E. on 9/9/2023

Leslee E. on 9/14/2023

Dr. L. on 9/20/2023

Douglas P. on 9/25/2023

Samuel H. on 9/29/2023

Sajid S. on 10/2/2023

pushpinder s. on 10/15/2023

Rachael S. on 10/16/2023

JOSEPH B. on 10/16/2023

Kenneth W. on 10/24/2023

Mark P. on 10/31/2023

David L. on 11/5/2023

Jeffrey B. on 12/8/2023

Tulin B. on 2/7/2024

Silas I. on 3/15/2024

Vasco M. on 3/27/2024

Bogdana T. on 4/3/2024

Michael G. on 8/2/2024

Terry K. on 8/4/2024

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6643 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7889.5 hours of CE.

Single Activity

Take this single activity

$25 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$139 per 1 year per user